DR reports serving as an uncompensated advisor for MSD, Regeneron, Bristol-Myers Squibb, GlaxoSmithKline, and Sanofi non-financial support from MSD and GlaxoSmithKline grants from Roche, GlaxoSmithKline, Regeneron, and Bristol-Myers Squibb and funding to their institution to support study conduct from MSD. KJH reports personal fees for serving as an advisory board member from MSD, AstraZeneca, Amgen, Boehringer Ingelheim, Merck Serono, Mersana, Oncolys, Pfizer, Replimmune, and Vyriad personal fees for serving as a speaker from MSD, AstraZeneca, Amgen, and Merck Serono honoraria from MSD, AstraZeneca, Amgen, Boehringer Ingelheim, Merck Serono, Pfizer, Replimmune, and Vyriad and funding to their institution to support study conduct from MSD.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |